Valuation : Abbott Laboratories

Market Cap 197B 169B 159B 145B 274B 18,857B 274B 1,879B 734B 9,504B 741B 725B 31,453B P/E 2026 *
32.7x
P/E 2027 * 25.2x
Enterprise Value 221B 190B 178B 163B 307B 21,143B 308B 2,107B 824B 10,656B 831B 813B 35,267B EV / Sales 2026 *
4.4x
EV / Sales 2027 * 4x
Free-Float
86.16%
Yield 2026 *
2.25%
Yield 2027 * 2.4%
1 day-1.42%
1 week-2.23%
Current month+5.57%
1 month+6.79%
3 months+30.24%
6 months-4.09%
Current year-10.93%
1 week 111.29
Extreme 111.29
117.34
1 month 102.89
Extreme 102.89
117.34
Current year 81.97
Extreme 81.97
129.46
1 year 81.97
Extreme 81.97
137.49
3 years 81.97
Extreme 81.97
141.23
5 years 81.97
Extreme 81.97
142.6
10 years 37.38
Extreme 37.38
142.6
Manager TitleAgeSince
Chief Executive Officer 52 2020-03-30
Director of Finance/CFO 53 2023-08-31
Chief Investment Officer 51 -
Director TitleAgeSince
Director/Board Member 64 2011-12-08
Director/Board Member 67 2011-12-08
Director/Board Member 71 2017-02-15
Date Insider Type Main position Quantity % Market Cap.
8/12/26 Other

EXECUTIVE VICE PRESIDENT

-12 0.0000%
6/30/26 Free

Director

416 0.0000%
6/30/26 Free

Director

432 0.0000%
Change 5-day change 1-year change 3-year change Capi.($)
-2.20%-2.23%-15.11%+8.56% 197B
-2.23%-2.52%-2.26%+10.54% 118B
-2.00%+2.08%+10.56%+78.08% 62.55B
-2.00%-3.74%+27.02%+53.48% 52.4B
-1.09%+0.27%-3.72%-33.18% 51.81B
+0.37%-1.03%+16.90%-10.07% 33.57B
+0.20%+6.35% - - 30.34B
-1.09%-2.17%+40.70%-14.20% 24.63B
-0.47%+3.56%-3.25%+19.21% 23.81B
-1.60%-1.18%-6.43%+2.26% 23.09B
Average -0.96%+0.78%+7.16%+12.74% 61.74B
Weighted average by Cap. -1.18%+0.07%-0.04%+14.85%

Financials

2026 *2027 *
Net sales 50.3B 43.18B 40.43B 37.02B 69.73B 4,804B 69.93B 479B 187B 2,421B 189B 185B 8,014B 54.65B 46.91B 43.92B 40.21B 75.75B 5,219B 75.97B 520B 203B 2,630B 205B 201B 8,706B
Net income 6.23B 5.35B 5.01B 4.59B 8.64B 595B 8.66B 59.31B 23.19B 300B 23.4B 22.89B 993B 7.92B 6.8B 6.37B 5.83B 10.99B 757B 11.02B 75.41B 29.48B 381B 29.75B 29.11B 1,262B
Net Debt 23.94B 20.55B 19.24B 17.62B 33.19B 2,286B 33.28B 228B 89.06B 1,152B 89.88B 87.94B 3,814B 20.96B 17.99B 16.84B 15.42B 29.05B 2,002B 29.13B 199B 77.96B 1,009B 78.68B 76.98B 3,339B
Logo Abbott Laboratories
Abbott Laboratories specializes in the research, development, manufacturing and marketing of pharmaceutical and medical products. Net sales break down by family of products as follows: - vascular devices (48.3%): endoprosthetic systems, dilation catheters, arterial closures, etc.; - diagnostic systems and instruments (20.2%); - nutrition products (19.1%): pediatric nutrition products, nutritional supplements, and dietetic products; - medicine (12.4%): anesthetics, antiviral products, antibiotics, inhibitors, anti-inflammatories, etc. Net sales are distributed geographically as follows: the United States (38.7%), Germany (6.2%), China (4.3%), India (4.2%), Switzerland (4.2%), Japan (3.3%), the United Kingdom (3%) and others (36.1%).
Employees
115,000
Date Price Change Volume
26-08-27 $111.59 -2.20% 6,993,926
26-08-26 $114.10 -1.75% 6,959,229
26-08-25 $116.13 -0.46% 7,503,742
26-08-24 $116.67 +0.03% 5,917,080
26-08-21 $116.64 +2.19% 9,931,504
Trader
Investor
Global
Quality
ESG MSCI
BBB
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
27
Last Close Price
114.10USD
Average target price
120.20USD
Spread / Average Target
+5.35%

Quarterly revenue - Rate of surprise